# Synaptrix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/synaptrix

- Industry: Medical Devices & Equipment
- Headquarters: Alpharetta, US
- Website: www.novabloc.com
- Total disclosed funding: $10M
- Latest round: Series A (Nov 8, 2024)
- Investors on record: 4

## About

Founded in 2023, and based in Georgia, US, Synaptrix, Inc. operates as a medical technology company that offers pain management solutions. In November 2024, Synaptrix raised USD 10 million in series A funding led by Hatteras Venture Partners, Rex Health Ventures, Avanos Medical, Inc., and Portal Innovations. As of 2024, the company is led by its CEO, Shyamy Sastry.

Synaptrix's core offering is the NOVABLOC Pain-Free Knee, an investigational device targeting postoperative pain management for knee surgery patients. The company’s neuromodulation device, NOVABLOC™, designed to provide long-lasting pain relief without the need for opioids. The device is specifically designed to target the nerves responsible for transmitting pain signals from the surgical site.

The company plans to utilize the November 2024 funding raised to support a pivotal study, regulatory submission, and commercialization of its proprietary NOVABLOC system, a drug-free solution for postoperative pain management.

## Funding rounds

- Series A, Nov 8, 2024, $10M — Hatteras Venture Partners, Rex Health Ventures, Portal Innovations, Avanos Medical, Inc.

## Investors

- Hatteras Venture Partners (https://capitalatlas.ai/funds/hatteras-venture-partners) — Series A
- Rex Health Ventures (https://capitalatlas.ai/funds/rex-health-ventures) — Series A
- Portal Innovations (https://capitalatlas.ai/funds/portal-innovations) — Series A
- Avanos Medical, Inc. — Series A